With their only treatment found in the grocery aisle and not behind the pharmacist's counter, celiac disease patients have relied upon delicious gluten-free recipes and cooking tips to navigate their medically necessary diet. As research continues to prove the need for a non-dietary therapy and scientists move closer to developing a pharmaceutical treatment, it is important for patients to learn more about the field of immunology, a critical piece to the celiac disease puzzle but one that is often left out of the patient education, as well as understand the basics about the drug development and approval process.
Join NFCA as Francisco Leon, MD, PhD, Vice President of Immunology Translational Medicine at Janssen Pharmaceutical Companies of Johnson and Johnson; and Ken Kilgore, MS, PhD, Director of ImmunoPharmacology in the Immunology Therapeutic Area at Janssen Pharmaceutical Companies of Johnson and Johnson explain the basics of immunology and outline the drug development and approval process.
When: Tuesday, June 11, 2013
Where: Your computer
Time: 8:30 p.m. EDT/5:30 p.m. PDT
This Webinar is free of charge and the only requirement is a working Internet connection!
Please Note: To ensure that you receive our follow-up email, please add the National Foundation for Celiac Awareness (National_Foundation_for_Celiac_A@mail.vresp.com) to your email safe senders list, address book or contact list. Please make sure to enter your email address correctly when registering for each webinar, as we will use that email address when sending our follow-up email.
Please note that if you have unsubscribed from any of NFCA's emails, including the monthly e-newsletter, you will not be able to receive follow-up emails at that email address. You will need to register for webinars using a different email address.